|
US5705187A
(en)
*
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
|
AU642066B2
(en)
*
|
1991-01-25 |
1993-10-07 |
Nanosystems L.L.C. |
X-ray contrast compositions useful in medical imaging
|
|
US5552160A
(en)
*
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
AU3662093A
(en)
*
|
1992-02-14 |
1993-09-03 |
Robert Lamb |
Phosphate derivatives of vitamin e to protect cells from effects of aging and injury
|
|
DE4221268C2
(de)
*
|
1992-06-26 |
1997-06-12 |
Lancaster Group Ag |
Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
|
|
US5464696A
(en)
*
|
1992-08-13 |
1995-11-07 |
Bracco International B.V. |
Particles for NMR imaging
|
|
US5336507A
(en)
*
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
|
US20070117862A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030073642A1
(en)
*
|
1993-02-22 |
2003-04-17 |
American Bioscience, Inc. |
Methods and formulations for delivery of pharmacologically active agents
|
|
FR2702160B1
(fr)
*
|
1993-03-02 |
1995-06-02 |
Biovecteurs As |
Vecteurs particulaires synthétiques et procédé de préparation.
|
|
DE19609538A1
(de)
*
|
1996-03-11 |
1997-09-18 |
Basf Ag |
Feinverteilte Carotinoid- und Retinoidsuspensionen und Verfahren zu ihrer Herstellung
|
|
DE4322158C2
(de)
*
|
1993-07-03 |
1997-04-10 |
Rhone Poulenc Rorer Gmbh |
Phospholipidische Zusammensetzung sowie Verwendung einer derartigen Zusammensetzung
|
|
US5393461A
(en)
*
|
1993-10-04 |
1995-02-28 |
Rtd Corporation |
Preparation of stable aqueous emulsions of water-insoluble particles
|
|
JP4484247B2
(ja)
*
|
1995-02-24 |
2010-06-16 |
エラン ファーマ インターナショナル，リミティド |
ナノ粒子分散体を含有するエアロゾル
|
|
US5747001A
(en)
*
|
1995-02-24 |
1998-05-05 |
Nanosystems, L.L.C. |
Aerosols containing beclomethazone nanoparticle dispersions
|
|
DE19511276C2
(de)
*
|
1995-03-27 |
1999-02-18 |
Immuno Ag |
Adjuvans auf der Basis kolloidaler Eisenverbindungen
|
|
US5788959A
(en)
|
1995-04-24 |
1998-08-04 |
University Of Maryland, Baltimore County |
Drug delivery device and method for employing the same
|
|
US5785975A
(en)
*
|
1995-06-26 |
1998-07-28 |
Research Triangle Pharmaceuticals |
Adjuvant compositions and vaccine formulations comprising same
|
|
US5931809A
(en)
*
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
|
US5834025A
(en)
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
|
US6576264B1
(en)
|
1995-10-17 |
2003-06-10 |
Skyepharma Canada Inc. |
Insoluble drug delivery
|
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
|
HU226608B1
(hu)
*
|
1996-08-22 |
2009-04-28 |
Rtp Pharma Corp |
Vízoldhatalan anyagok mikrorészecskéit tartalmazó készítmények és ezek elõállítására szolgáló eljárások
|
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
US20070092563A1
(en)
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
CN1146402C
(zh)
|
1996-12-20 |
2004-04-21 |
阿尔萨公司 |
凝胶组合物及方法
|
|
FR2757768B1
(fr)
*
|
1996-12-27 |
1999-04-02 |
Biovector Therapeutics Sa |
Vecteur particulaire homeocharge et composition pharmaceutique ou cosmetique le contenant
|
|
CA2282378C
(en)
*
|
1997-02-27 |
2008-12-30 |
Yoshitomi Pharmaceutical Industries Ltd. |
Pharmaceutical composition
|
|
WO1998047492A1
(en)
*
|
1997-04-18 |
1998-10-29 |
Vertex Pharmaceuticals Incorporated |
Nanosized aspartyl protease inhibitors
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
KR100904931B1
(ko)
*
|
1997-06-27 |
2009-06-29 |
아브락시스 바이오사이언스, 엘엘씨 |
나노 입자 및 그의 제조 방법
|
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
IL136488A0
(en)
*
|
1997-12-02 |
2001-06-14 |
Powderject Vaccines Inc |
Transdermal delivery of particulate vaccine compositions
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
ATE241363T1
(de)
*
|
1998-02-11 |
2003-06-15 |
Rtp Pharma Corp |
Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
SE9801287D0
(sv)
*
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Incorporation of active substances in carrier matrixes
|
|
DE69914742T2
(de)
|
1998-05-29 |
2004-11-25 |
Skyepharma Canada Inc., Verdun |
Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
|
|
US7343710B2
(en)
*
|
1998-07-03 |
2008-03-18 |
I.D.A Limited |
Method and apparatus for controlling pests
|
|
GB9814507D0
(en)
*
|
1998-07-03 |
1998-09-02 |
Univ Southampton |
A method and apparatus for controlling pests
|
|
EP1105096B1
(en)
*
|
1998-08-19 |
2003-10-29 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
|
DE69930294T2
(de)
*
|
1998-10-19 |
2006-11-02 |
Powderject Vaccines, Inc., Madison |
Minimale promotoren und ihre verwendung
|
|
US6881723B1
(en)
|
1998-11-05 |
2005-04-19 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
US6180136B1
(en)
|
1998-11-10 |
2001-01-30 |
Idexx Laboratories, Inc. |
Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
|
HUP0105089A3
(en)
*
|
1998-11-20 |
2002-09-30 |
Skyepharma Canada Inc |
Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
|
|
US6251886B1
(en)
|
1998-12-07 |
2001-06-26 |
Schering Corporation |
Methods of using temozolomide in the treatment of cancers
|
|
US6682758B1
(en)
|
1998-12-22 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-insoluble drug delivery system
|
|
DE19901687B4
(de)
*
|
1999-01-18 |
2006-06-01 |
Grünenthal GmbH |
Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
|
|
KR100359252B1
(ko)
*
|
1999-12-21 |
2002-11-04 |
주식회사 엘지생명과학 |
항원을 포함하는 고체상 미세입자 및 이를 포함하는 제제
|
|
AU3593200A
(en)
|
1999-02-09 |
2000-08-29 |
Powderject Vaccines, Inc. |
(mycobacterium tuberculosis), immunization
|
|
WO2000050009A1
(en)
*
|
1999-02-26 |
2000-08-31 |
Idexx Laboratories, Inc. |
Methods for administering pharmacologically active compounds to vertebrates
|
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6511814B1
(en)
|
1999-03-26 |
2003-01-28 |
Idexx Laboratories, Inc. |
Method and device for detecting analytes in fluids
|
|
US6551842B1
(en)
|
1999-03-26 |
2003-04-22 |
Idexx Laboratories, Inc. |
Method and device for detecting analytes in fluids
|
|
US6602719B1
(en)
|
1999-03-26 |
2003-08-05 |
Idexx Laboratories, Inc. |
Method and device for detecting analytes in fluids
|
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
SK702002A3
(en)
*
|
1999-07-16 |
2002-05-09 |
Unilever Nv |
Hardstock fat, process for producing thereof, pourable fatty dispersion comprising same and use such of a dispersion
|
|
AU779403B2
(en)
|
1999-08-24 |
2005-01-20 |
Teva Pharmaceutical Industries Ltd. |
A vaccine composition and method of using the same
|
|
US6592869B2
(en)
|
1999-08-24 |
2003-07-15 |
Teva Pharmaceutical Industries, Ltd. |
Vaccine composition and method of using the same
|
|
CA2383233C
(en)
*
|
1999-09-21 |
2010-06-08 |
Rtp Pharma Inc. |
Surface modified particulate compositions of biologically active substances
|
|
US7045049B1
(en)
*
|
1999-10-01 |
2006-05-16 |
Nanoplex Technologies, Inc. |
Method of manufacture of colloidal rod particles as nanobar codes
|
|
US6919009B2
(en)
*
|
1999-10-01 |
2005-07-19 |
Nanoplex Technologies, Inc. |
Method of manufacture of colloidal rod particles as nanobarcodes
|
|
US20040178076A1
(en)
*
|
1999-10-01 |
2004-09-16 |
Stonas Walter J. |
Method of manufacture of colloidal rod particles as nanobarcodes
|
|
US7225082B1
(en)
|
1999-10-01 |
2007-05-29 |
Oxonica, Inc. |
Colloidal rod particles as nanobar codes
|
|
US20050032226A1
(en)
*
|
1999-10-01 |
2005-02-10 |
Natan Michael J. |
Encoded nanoparticles in paper manufacture
|
|
US20040209376A1
(en)
*
|
1999-10-01 |
2004-10-21 |
Surromed, Inc. |
Assemblies of differentiable segmented particles
|
|
US7196066B1
(en)
*
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
|
GB0009773D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Univ Cardiff |
Particulate composition
|
|
US6682761B2
(en)
|
2000-04-20 |
2004-01-27 |
Rtp Pharma, Inc. |
Water-insoluble drug particle process
|
|
US6604698B2
(en)
|
2000-05-10 |
2003-08-12 |
Skyepharma Canada, Inc. |
Media milling
|
|
EP2036540A3
(en)
|
2000-06-16 |
2009-12-16 |
Jagotec AG |
Improved injectable dispersions of propofol
|
|
DE60137943D1
(de)
|
2000-08-31 |
2009-04-23 |
Jagotec Ag |
Gemahlene partikel
|
|
US6579519B2
(en)
*
|
2000-09-18 |
2003-06-17 |
Registrar, University Of Delhi |
Sustained release and long residing ophthalmic formulation and the process of preparing the same
|
|
TWI354568B
(en)
*
|
2000-09-20 |
2011-12-21 |
Jagotec Ag |
Insoluble drug particle compositions with improved
|
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
|
US20040077604A1
(en)
*
|
2001-12-19 |
2004-04-22 |
Lenard Lichtenberger |
Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
|
|
EP1343529B1
(en)
*
|
2000-12-19 |
2008-11-19 |
The Board of Regents, The University of Texas System |
Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
|
|
US20100173876A1
(en)
*
|
2000-12-19 |
2010-07-08 |
The Board Of Regents Of The University Of Texas System |
Oil-based nsaid compositions and methods for making and using same
|
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US20020150615A1
(en)
*
|
2001-02-12 |
2002-10-17 |
Howard Sands |
Injectable pharmaceutical composition comprising microdroplets of a camptothecin
|
|
US6509027B2
(en)
|
2001-02-12 |
2003-01-21 |
Supergen, Inc. |
Injectable pharmaceutical composition comprising coated particles of camptothecin
|
|
US6497896B2
(en)
|
2001-02-12 |
2002-12-24 |
Supergen, Inc. |
Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
|
|
ATE357216T1
(de)
*
|
2001-02-22 |
2007-04-15 |
Jagotec Ag |
Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
|
|
WO2002074247A2
(en)
*
|
2001-03-19 |
2002-09-26 |
Praecis Pharmaceuticals Incorporated |
Pharmaceutical formulations for sustained release
|
|
PT1389089E
(pt)
*
|
2001-03-27 |
2009-11-30 |
Phares Pharm Res Nv |
Processo e composição para solubilizar um composto biologicamente activo com uma baixa solubilidade em água
|
|
AU2002307090A1
(en)
*
|
2001-04-03 |
2002-10-21 |
Surromed, Inc. |
Methods and reagents for multiplexed analyte capture, surface array self-assembly, and analysis of complex biological samples
|
|
CA2441108A1
(en)
*
|
2001-04-05 |
2002-10-17 |
Universite Laval |
Process for making delivery matrix and uses thereof
|
|
GB0114532D0
(en)
*
|
2001-06-14 |
2001-08-08 |
Jagotec Ag |
Novel compositions
|
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
US7758890B2
(en)
*
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
|
GB0119480D0
(en)
*
|
2001-08-09 |
2001-10-03 |
Jagotec Ag |
Novel compositions
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
EP1429749A2
(en)
*
|
2001-09-26 |
2004-06-23 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
|
RU2292871C2
(ru)
*
|
2001-10-19 |
2007-02-10 |
Айдекс Лэборэтериз, Инк. |
Инъецируемые композиции для контролируемой доставки фармакологически активного соединения
|
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
|
KR100836035B1
(ko)
*
|
2002-02-19 |
2008-06-09 |
(주)아모레퍼시픽 |
포화 및 불포화 레시틴 함유 나노에멀젼 및 이를 함유하는화장료 조성물
|
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
CA2479665C
(en)
*
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US7101566B2
(en)
*
|
2002-06-28 |
2006-09-05 |
Ethicon, Inc. |
Polymer coated microparticles for sustained release
|
|
US20040247661A1
(en)
*
|
2002-07-03 |
2004-12-09 |
Dov Michaeli |
Liposomal vaccine
|
|
US20050169979A1
(en)
*
|
2002-07-03 |
2005-08-04 |
Dov Michaeli |
Liposomal vaccine
|
|
US7838034B2
(en)
*
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
|
LT2891666T
(lt)
|
2002-10-16 |
2017-10-10 |
Purdue Pharma L.P. |
Antikūnai, kurie prisiriša su ląstelėmis susijusį ca 125/o722p ir jų naudojimo būdas
|
|
RU2331424C2
(ru)
*
|
2002-12-13 |
2008-08-20 |
Джеготек Аг |
Топический состав, содержащий наночастицы спиронолактона
|
|
EP1569623B1
(en)
*
|
2002-12-13 |
2008-10-15 |
Jagotec Ag |
A topical nanoparticulate spironolactone formulation
|
|
US7731947B2
(en)
*
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
WO2005013919A2
(en)
|
2003-03-04 |
2005-02-17 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
|
WO2004113869A2
(en)
*
|
2003-06-17 |
2004-12-29 |
Surromed, Inc. |
Labeling and authentication of metal objects
|
|
DE10327839A1
(de)
*
|
2003-06-20 |
2005-01-05 |
Arvinmeritor Gmbh |
Fahrzeugdachmodul
|
|
US8986736B2
(en)
*
|
2003-06-24 |
2015-03-24 |
Baxter International Inc. |
Method for delivering particulate drugs to tissues
|
|
CA2540695A1
(en)
*
|
2003-06-24 |
2004-12-29 |
Baxter International Inc. |
Specific delivery of drugs to the brain
|
|
US20080051373A1
(en)
*
|
2003-07-31 |
2008-02-28 |
The Board Of Regents Of The University Of Texas System |
Parenteral preparations of GI-safer phospholipid-associated anti-inflammatories and methods of preparation and use
|
|
US20050049209A1
(en)
*
|
2003-08-06 |
2005-03-03 |
Chen Andrew Xian |
Pharmaceutical compositions for delivering macrolides
|
|
JP2005097295A
(ja)
*
|
2003-09-01 |
2005-04-14 |
Wakunaga Pharmaceut Co Ltd |
ビタミン安定液剤
|
|
ES2394208T3
(es)
|
2003-09-22 |
2013-01-23 |
Baxter International Inc. |
Esterilización a alta presión para la esterilización definitiva de preparaciones farmacéuticas y productos médicos
|
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
|
KR20060123384A
(ko)
*
|
2003-12-24 |
2006-12-01 |
가부시키가이샤 엘티티 바이오파마 |
약물을 함유하는 나노 입자 및 그 제조 방법, 그리고 당해나노 입자로 이루어지는 비경구 투여용 제제
|
|
KR20060135729A
(ko)
*
|
2004-01-29 |
2006-12-29 |
백스터 인터내셔널 인코포레이티드 |
중추신경계 전달 증가를 위한 항레트로바이러스제의나노현탁액
|
|
US20050196416A1
(en)
*
|
2004-02-05 |
2005-09-08 |
Kipp James E. |
Dispersions prepared by use of self-stabilizing agents
|
|
WO2005095950A1
(en)
*
|
2004-03-30 |
2005-10-13 |
Pfizer Products Inc. |
Method and device for evaluation of pharmaceutical compositions
|
|
WO2005117831A1
(en)
*
|
2004-05-28 |
2005-12-15 |
Schering Corporation |
Injectable pharmaceutical suspension comprising posaconazole
|
|
US20060160823A1
(en)
*
|
2004-05-28 |
2006-07-20 |
Leonore Witchey-Lakshmanan |
Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
|
|
US20060009469A1
(en)
*
|
2004-05-28 |
2006-01-12 |
Leonore Witchey-Lakshmanan |
Particulate-stabilized injectable pharmacutical compositions of posaconazole
|
|
BRPI0510271A
(pt)
*
|
2004-06-15 |
2007-10-30 |
Baxter Int |
aplicações ex-vivo agentes terapêuticos microparticulados
|
|
WO2006034147A2
(en)
*
|
2004-09-16 |
2006-03-30 |
Abraxis Bioscience, Inc. |
Compositions and methods for the preparation and administration of poorly water soluble drugs
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
CA2608930A1
(en)
*
|
2005-06-14 |
2006-12-28 |
Baxter International Inc. |
Pharmaceutical formulations for minimizing drug-drug interactions
|
|
EP1954245A2
(en)
*
|
2005-11-15 |
2008-08-13 |
Baxter International Inc. |
Compositions of lipoxygenase inhibitors
|
|
WO2007115134A2
(en)
|
2006-03-29 |
2007-10-11 |
Wayne State University |
Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
|
|
WO2008054508A2
(en)
*
|
2006-04-13 |
2008-05-08 |
Alza Corporation |
Stable nanosized amorphous drug
|
|
ATE481963T1
(de)
|
2006-05-30 |
2010-10-15 |
Intarcia Therapeutics Inc |
Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
|
|
US20080181957A1
(en)
*
|
2006-06-23 |
2008-07-31 |
Min Wei |
Increased amorphous stability of poorly water soluble drugs by nanosizing
|
|
EP2068833B1
(en)
*
|
2006-07-26 |
2013-01-09 |
The Board of Regents of the University of Texas System |
Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use
|
|
CA2670821C
(en)
|
2006-08-09 |
2012-05-15 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
|
EP2061583B1
(en)
*
|
2006-09-14 |
2019-04-10 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Organic nanoparticles obtained from microemulsions by solvent evaporation
|
|
AR063704A1
(es)
*
|
2006-09-14 |
2009-02-11 |
Makhteshim Chem Works Ltd |
Nanoparticulas de pesticida obtenida obtenidas a partir de microemulsiones y nanoemulsiones
|
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
|
WO2008080047A2
(en)
*
|
2006-12-23 |
2008-07-03 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
|
US20100119612A1
(en)
*
|
2007-04-17 |
2010-05-13 |
Bend Research, Inc |
Nanoparticles comprising non-crystalline drug
|
|
WO2008133908A2
(en)
|
2007-04-23 |
2008-11-06 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
WO2008135855A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
|
WO2008135828A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
US20100080852A1
(en)
*
|
2007-05-03 |
2010-04-01 |
Ronald Arthur Beyerinck |
Phamaceutical composition comprising nanoparticles and casein
|
|
US8530463B2
(en)
*
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
WO2008137960A1
(en)
*
|
2007-05-07 |
2008-11-13 |
Questor Pharmaceuticals, Inc. |
Nasal administration of benzodiazepines
|
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
US8974827B2
(en)
*
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
|
US20080319039A1
(en)
*
|
2007-06-25 |
2008-12-25 |
Jacqueline Rose Bersch |
Unit dosage forms of temozolomide
|
|
EP2178518A2
(en)
*
|
2007-07-13 |
2010-04-28 |
Bend Research, Inc |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
AU2008303023B2
(en)
|
2007-09-27 |
2014-01-09 |
Immunovaccine Technologies Inc. |
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
|
|
US9233078B2
(en)
*
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
|
WO2009073215A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
PL2244783T3
(pl)
|
2008-01-22 |
2020-08-24 |
Board Of Regents, The University Of Texas System |
Kompozycje lotnego anestetyku i sposoby stosowania
|
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
RU2496482C2
(ru)
|
2008-03-05 |
2013-10-27 |
Бакстер Интернэшнл Инк. |
Композиции и способы для доставки лекарственных средств
|
|
CA2718416C
(en)
*
|
2008-03-13 |
2018-01-02 |
Mallinckrodt Inc. |
Multi-function, foot-activated controller for imaging system
|
|
AU2009228093B2
(en)
|
2008-03-28 |
2014-08-07 |
Neurelis, Inc. |
Administration of benzodiazepine compositions
|
|
EP2296696B1
(en)
|
2008-06-05 |
2014-08-27 |
ImmunoVaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
GB2462022B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
|
|
WO2010075517A2
(en)
*
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Nucleoside analogs
|
|
AR074977A1
(es)
|
2008-12-23 |
2011-03-02 |
Pharmasset Inc |
Sintesis de nucleosidos de purina
|
|
TW201026715A
(en)
|
2008-12-23 |
2010-07-16 |
Pharmasset Inc |
Nucleoside phosphoramidates
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
EP3195896A1
(en)
|
2009-05-05 |
2017-07-26 |
Board of Regents, The University of Texas System |
Novel formulations of volatile anesthetics and methods of use for reducing inflammation
|
|
US10952965B2
(en)
*
|
2009-05-15 |
2021-03-23 |
Baxter International Inc. |
Compositions and methods for drug delivery
|
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
PL2462246T3
(pl)
|
2009-09-28 |
2018-02-28 |
Intarcia Therapeutics, Inc |
Szybkie ustalenie i/lub zakończenie dostarczania leku zasadniczo w stanie równowagi dynamicznej
|
|
WO2011123672A1
(en)
|
2010-03-31 |
2011-10-06 |
Pharmasset, Inc. |
Purine nucleoside phosphoramidate
|
|
AP2012006535A0
(en)
|
2010-03-31 |
2012-10-31 |
Gilead Pharmasset Llc |
Stereoselective synthesis of phosphorous containing actives
|
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
TW201242974A
(en)
|
2010-11-30 |
2012-11-01 |
Gilead Pharmasset Llc |
Compounds
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
JP2014504184A
(ja)
|
2010-12-01 |
2014-02-20 |
スパイナル・モデュレーション・インコーポレイテッド |
神経構造への薬剤の直接送達
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
EP3415139B8
(en)
|
2011-06-14 |
2022-05-18 |
Neurelis, Inc. |
Administration of benzodiazepine
|
|
KR102180667B1
(ko)
|
2011-09-29 |
2020-11-20 |
피엘엑스 옵코 인코포레이티드 |
위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
|
|
BR112014007927B1
(pt)
|
2011-10-06 |
2021-04-13 |
Immunovaccine Technologies Inc |
Composições de lipossoma compreendendo um adjuvante e usos das referidas composições e usos das referidas composições
|
|
EP4218808A3
(en)
|
2012-03-12 |
2023-08-09 |
Advanced BioAdjuvants, LLC |
Adjuvant and vaccine compositions
|
|
CA2906072C
(en)
|
2013-03-15 |
2023-01-10 |
Vapogenix, Inc. |
Analgesic compositions comprising halogenated volatile compounds
|
|
RU2541156C1
(ru)
*
|
2013-07-09 |
2015-02-10 |
Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" |
Трансдермальное антигельминтное средство на основе кремнийорганических ниосом с альбендазолом
|
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
MA44390A
(fr)
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
Systèmes de mise en place et de retrait d'implant
|
|
WO2016205423A2
(en)
|
2015-06-15 |
2016-12-22 |
Lipocine Inc. |
Composition and method for oral delivery of androgen prodrugs
|
|
MA41770A
(fr)
*
|
2015-12-08 |
2021-04-28 |
Verano Ilac Sanayi Ve Ticaret A S |
Composition injectable de ricobendazole
|
|
KR20240037175A
(ko)
|
2016-05-16 |
2024-03-21 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
US11559530B2
(en)
|
2016-11-28 |
2023-01-24 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
|
EP3565580B1
(en)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
|
|
JP2021531348A
(ja)
|
2018-07-20 |
2021-11-18 |
リポシン，インク． |
肝臓病
|
|
CA3172595A1
(en)
|
2020-03-26 |
2021-09-30 |
Ronald Zimmerman |
Pharmaceutical carriers capable of ph dependent reconstitution and methods for making and using same
|
|
US11992483B2
(en)
|
2021-03-31 |
2024-05-28 |
Cali Biosciences Us, Llc |
Emulsions for local anesthetics
|
|
CN116687847B
(zh)
*
|
2023-06-26 |
2024-03-29 |
石家庄四药有限公司 |
一种药物微晶注射液及其制备方法
|